Corcept Therapeutics (CORT) Capital Expenditures Growth (3y) (2015 - 2025)
Corcept Therapeutics (CORT) Capital Expenditures Growth (3y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Corcept Therapeutics |
8.35 Bn |
8.01 Bn |
162.02 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
17.27% |
| Jun 30, 2025 |
44.22% |
| Mar 31, 2025 |
105.41% |
| Dec 31, 2024 |
23.01% |
| Sep 30, 2024 |
117.46% |
| Jun 30, 2024 |
51.77% |
| Sep 30, 2023 |
-62.79% |
| Jun 30, 2023 |
29.47% |
| Dec 31, 2022 |
-38.76% |
| Sep 30, 2022 |
7.06% |
| Jun 30, 2022 |
-64.08% |
| Mar 31, 2022 |
-63.99% |
| Dec 31, 2021 |
-16.83% |
| Sep 30, 2021 |
52.31% |
| Jun 30, 2021 |
23.61% |
| Mar 31, 2021 |
17.84% |
| Dec 31, 2020 |
145.86% |
| Sep 30, 2020 |
106.11% |
| Jun 30, 2020 |
-38.08% |
| Mar 31, 2020 |
-27.45% |
